Site Search
Join Muvizu
Messages in this topic - RSS

Home ? Competitions, Events & News ? Chronic Pain Market was valued at USD 77.79 billio

Please log in or register, then complete your details to create a post.
09/05/2025 19:55:58

nikitapawar
nikitapawar
Posts: 3 		The Global Chronic Pain Market was valued at USD 77.79 billion in 2023 and is projected to grow to USD 117.37 billion by 2031, exhibiting a CAGR of 5.36% during the forecast period. The increasing prevalence of chronic pain conditions, rising geriatric population, and advancements in pain management therapies are driving market growth.
Read Complete Report Details: https://www.kingsresearch.com/chronic-pain-market-879
Key Market Drivers1. Rising Prevalence of Chronic Pain ConditionsChronic pain affects over 20% of the global population, with conditions such as neuropathy, arthritis, back pain, and cancer pain being the most common.
2. Growth in Geriatric PopulationAging populations worldwide are more prone to musculoskeletal and neuropathic pain, increasing demand for pain management drugs and devices.
3. Advancements in Pain Management TherapiesDevelopment of novel analgesics, nerve stimulation devices, and non-opioid treatments is transforming the chronic pain management landscape.
4. Increasing Awareness and DiagnosisBetter healthcare access and awareness programs are improving early diagnosis and treatment rates for chronic pain conditions.
Market SegmentationBy ProductDrugs:
Opioids (Morphine, Fentanyl, Oxycodone)
NSAIDs (Ibuprofen, Naproxen)
Anticonvulsants (Gabapentin, Pregabalin)
Antidepressants (Amitriptyline, Duloxetine)
Topical Analgesics
Devices:
Neurostimulation Devices (Spinal Cord Stimulators, TENS units)
Infusion Pumps
Radiofrequency Ablation Devices
By IndicationNeuropathic Pain (Diabetic neuropathy, postherpetic neuralgia)
Arthritis Pain (Osteoarthritis, Rheumatoid Arthritis)
Chronic Back Pain
Cancer Pain
Others (Fibromyalgia, Migraine, Post-surgical Pain)
By ApplicationMusculoskeletal – Arthritis, back pain, fibromyalgia
Neuropathy – Diabetic neuropathy, post-surgical neuropathy
Oncology – Cancer-related pain management
Others
By Distribution ChannelHospitals & Clinics
Retail Pharmacies
Online Pharmacies
Regional InsightsNorth America – Largest market due to high prevalence of chronic pain, advanced healthcare infrastructure, and opioid crisis-driven non-opioid therapies.
Europe – Growing demand for non-opioid pain management and neurostimulation devices.
Asia-Pacific – Rapid growth driven by aging populations, increasing healthcare spending, and expansion of pain clinics.
Rest of the World – Improving access to pain management therapies in Latin America, the Middle East, and Africa.
Future Trends & ChallengesOpportunities:Emerging non-opioid pain management solutions (CBD-based products, regenerative medicine, neuromodulation).
AI & digital health integration in pain tracking and personalized treatment.
Growing adoption of wearable pain relief devices.
Challenges:Regulatory restrictions on opioids impacting traditional pain management approaches.
High cost of advanced pain management devices.
Limited awareness in developing regions.
The Chronic Pain Market is expected to witness steady growth, driven by technological advancements, non-opioid alternatives, and increasing global awareness about effective pain management solutions
permalink
Please log in or register, then complete your details to create a post.

Home ? Competitions, Events & News ? Chronic Pain Market was valued at USD 77.79 billio

About

Media

Legal

Muvizu

Muvizu is easy to use 3D animation software that allows anyone to create high quality animations quickly and easily. Muvizu’s animation engine is ideal for storytellers, animators, teachers and businesses looking to engage, enchant and delight audiences with animated content.